A safe place to talk about Crohn’s
Published in eyeforpharma April 2017 by Mariel Metcalfe
Anxiety and embarrassment are a vicious circle for people with Crohn’s disease. The psychological and emotional effects of this complex and often unrecognised condition not only dominate patients’ lives but raise the risk of further outbreaks.
Understanding and empathy around Crohn’s are in short supply. It is a relatively low-profile disease, with periods of remission broken by highly disruptive flare-ups. The very nature of those flare-ups tends to ensure that Crohn’s stays below the radar.
What next for the treatment of Psoriasis in Europe?
Research Director Laurent Chanroux investigates the changing market dynamics in Psoriasis in Europe.
Over the last decade, systemic biologic therapies for Psoriasis (PsO) have become widespread and the development of biological therapies has revolutionized the treatment of the disease. A chronic autoimmune disease, psoriasis has an estimated prevalence of 2.5% in Europe, representing approximately 15 million people, with 20–25% of these suffering from severe disease.
20 questions: Round 1
As it's our 20th year anniversary, we invited our employees to play our version 20 questions - this month "What's the biggest challenge you've overcome at Research Partnership?"
Brand tracking research
A common challenge for brand tracking is ensuring the research programme stays relevant to the brand’s current environment. In this video Quantitative Research Directors Karen Swords and Vicky McLellan outline this and some other key challenges of conducting a successful tracking study and how to overcome them.
Pharma China Annual Forum 2017
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China.
We are delighted to be presenting a paper at the Pharma China Annual Forum on 14th April 2017 in Shanghai, China. Representing Research Partnership will be Asia Pacific Director and emerging markets specialist Pei Li Teh, who will be presenting the paper ’Urban China’s Evolving Patient Journey’ from 14:30 – 15:00.